2488. Virologic Failure in ART Naïve Patients Initiating on a Dolutegravir or Elvitegravir-Based Regimen

BACKGROUND: Robust pharmacoeconomic modeling is dependent on high quality inputs, preferably from randomized clinical trials (RCT), but not all needed head to head comparisons occur in RCTs. We compared virologic outcomes in an antiretroviral (ART) naïve population initiating a dolutegravir (DTG) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohlfeiler, Michael, Schulman, Kathy, Fusco, Jennifer S, Punekar, Yogesh, Mills, Anthony, Priest, Julie, Oglesby, Alan, Fusco, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809617/
http://dx.doi.org/10.1093/ofid/ofz360.2166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809617/
http://dx.doi.org/10.1093/ofid/ofz360.2166

Ejemplares similares